Incontinentia pigmenti: Report on data from 2000 to 2013

Orphanet Journal of Rare Diseases

Volumn 9, Issue 1, 2014, Pages

  Fusco, Francesca ^a   Paciolla, Mariateresa ^a,b   Conte, Matilde Immacolata ^a   Pescatore, Alessandra ^a   Esposito, Elio ^a   Mirabelli, Peppino ^c   Lioi, Maria Brigida ^b   Ursini, Matilde Valeria ^a,c  

^a INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^b UNIVERSITY OF BASILICATA   (Italy)

^c IRCCS SDN   (Italy)

Author keywords

Database; Genomic disorder; Incontinentia pigmenti; Molecular diagnosis; Neuroectodermal disorder; Registry

Indexed keywords

ARTICLE; CLINICAL STUDY; COHORT ANALYSIS; DATA BASE; DISEASE REGISTRY; FEMALE; HUMAN; INCONTINENTIA PIGMENTI; INHERITANCE; MAJOR CLINICAL STUDY; MALE; MOLECULAR DIAGNOSIS; ONSET AGE; PEDIGREE; SKIN DEFECT; ADULT; NAIL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERSONAL EXPERIENCE; PHENOTYPE; POINT MUTATION;

COHORT STUDIES; FEMALE; HUMANS; INCONTINENTIA PIGMENTI; MALE;

EID: 84904018310     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-9-93     Document Type: Article

References (25)

1. Prevalence of rare diseases: bibliographic data Rare Diseases collection. Orphanet Report Serie, 2013 1 Listed in alphabetical order of disease or group of diseases, http://www.orpha.net/orphacom/cahiers/docs/GB/Prevalence-of-rare- diseases-by-alphabetical-list.pdf
2. Incontinentia pigmenti (Bloch-Sulzberger syndrome). Landy SJ, Donnai D, J Med Genet 1993 30 53 59 10.1136/jmg.30.1.53 8423608 (Pubitemid 23067559)
3. Incontinentia pigmenti. Scheuerle A, Ursini MV, GeneReviews® [Internet] Seattle: University of Washington, Pagon RA, Adam MP, Ardinger HH, Bird TD, Dolan CR, Fong CT, Smith RJH, Stephens K, Seattle WA, 2010 1993 2014 http://www.ncbi.nlm.nih.gov/books/NBK1472
4. The skin is not the predominant problem in incontinentia pigmenti. Goldberg MF, Arch Dermatol 2004 140 748 750 15210470 (Pubitemid 38747295)
5. Neurological findings in incontinentia pigmenti: a review. Meuwissen MEC, Mancini GMS, Eur J Med Genet 2012 55 323 331 10.1016/j.ejmg.2012.04.007 22564885
6. Systematic review of central nervous system anomalies in incontinentia pigmenti. Minić S, Trpinac D, Obradović M, Orphanet J Rare Dis 2013 8 25 35 doi:doi:10.1186/1750-1172-8-25 10.1186/1750-1172-8-25 23406512
7. Incontinentia pigmenti: learning disabilities are a fundamental hallmark of the disease. Pizzamiglio MR, Piccardi L, Bianchini F, Canzano L, Palermo L, Fusco F, D'Antuono G, Gelmini C, Garavelli L, Ursini MV, PLoS One 2014 9 87771 doi:10.1371/journal.pone.0087771. eCollection 2014 10.1371/journal.pone.0087771 24489960
8. Clinical study of 40 cases of incontinentia pigmenti. Hadj-Rabia S, Froidevaux D, Bodak N, Hamel-Teillac D, Smahi A, Touil Y, Fraitag S, de Prost Y, Bodemer C, Arch Dermatol 2003 139 1163 1170 12975158 (Pubitemid 37128378)
9. Genomic rearrangement in NEMO impairs NF-κB activation and is a cause of incontinentia pigmenti. Smahi A, Courtois G, Vabres P, Yamaoka S, Heuertz S, Munnich A, Israël A, Heiss NS, Klauck SM, Kioschis P, Wiemann S, Poustka A, Esposito T, Bardaro T, Gianfrancesco F, Ciccodicola A, D'Urso M, Woffendin H, Jakins T, Donnai D, Stewart H, Kenwrick SJ, Aradhya S, Yamagata T, Levy M, Lewis RA, Nelson DL, International Incontinentia Pigmenti (IP) Consortium, Nature 2000 405 466 472 10.1038/35013114 10839543 (Pubitemid 30367424)
10. Genomic architecture at the Incontinentia Pigmenti locus favours de novo pathological alleles through different mechanisms. Fusco F, Paciolla M, Napolitano F, Pescatore A, D'Addario I, Bal E, Lioi MB, Smahi A, Miano MG, Ursini MV, Hum Mol Genet 2012 21 1260 1271 10.1093/hmg/ddr556 22121116
11. Insight into IKBKG/NEMO locus: report of new mutations and complex genomic rearrangements leading to incontinentia pigmenti disease. Conte MI, Pescatore A, Paciolla M, Esposito E, Miano MG, Lioi MB, McAleer MA, Giardino G, Pignata C, Irvine AD, Scheuerle AE, Royer G, Hadj-Rabia S, Bodemer C, Bonnefont JP, Munnich A, Smahi A, Steffann J, Fusco F, Ursini MV, Hum Mutat 2014 35 165 177 10.1002/humu.22483 24339369
12. Signaling to NF-κB. Hayden MS, Ghosh S, Genes Dev 2004 18 2195 2224 10.1101/gad.1228704 15371334 (Pubitemid 39209568)
13. NEMO, NFκB signaling and incontinentia pigmenti. Nelson DL, Curr Opin Genet Dev 2006 16 282 288 10.1016/j.gde.2006.04.013 16647846
14. Molecular analysis of the genetic defect in a large cohort of IP patients and identification of novel NEMO mutations interfering with NF-κB activation. Fusco F, Bardaro T, Fimiani G, Mercadante V, Miano MG, Falco G, Israël A, Courtois G, D'Urso M, Ursini MV, Hum Mol Genet 2004 13 1763 1773 10.1093/hmg/ddh192 15229184 (Pubitemid 39173445)
15. Non-random X chromosome inactivation in mammalian cells. Migeon BR, Cytogenet Cell Genet 1998 80 142 148 10.1159/000014971 9678349 (Pubitemid 28330375)
16. Favorably skewed X-inactivation accounts for neurological sparing in female carriers of Menkes disease. Desai V, Donsante A, Swoboda KJ, Martensen M, Thompson J, Kaler SG, Clin Genet 2011 79 176 182 10.1111/j.1399-0004.2010. 01451.x 20497190
17. NEMO/IKKγ: linking NF-κB to human disease. Courtois G, Smahi A, Israël A, Trends Mol Med 2001 7 427 430 10.1016/S1471-4914(01)02154-2 11597506 (Pubitemid 32964151)
18. Clinical diagnosis of incontinentia pigmenti in a cohort of male patients. Fusco F, Fimiani G, Tadini G, Michele D, Ursini MV, J Am Acad Dermatol 2007 56 264 267 10.1016/j.jaad.2006.09.019 17224368 (Pubitemid 46074254)
19. Survival of male patients with incontinentia pigmenti carrying a lethal mutation can be explained by somatic mosaicism or Klinefelter syndrome. Kenwrick S, Woffendin H, Jakins T, Shuttleworth SG, Mayer E, Greenhalgh L, Whittaker J, Rugolotto S, Bardaro T, Esposito T, D'Urso M, Soli F, Turco A, Smahi A, Hamel-Teillac D, Lyonnet S, Bonnefont JP, Munnich A, Aradhya S, Kashork CD, Shaffer LG, Nelson DL, Levy M, Lewis RA, International IP Consortium, Am J Hum Genet 2001 69 1210 1217 11673821 (Pubitemid 33124202)
20. Alterations of the IKBKG locus and diseases: an update and a report of 13 novel mutations. Fusco F, Pescatore A, Bal E, Ghoul A, Paciolla M, Lioi MB, D'Urso M, Rabia SH, Bodemer C, Bonnefont JP, Munnich A, Miano MG, Smahi A, Ursini MV, Hum Mutat 2008 29 595 604 10.1002/humu.20739 18350553 (Pubitemid 351614582)
21. Clinical utility gene card for: Incontinentia Pigmenti. Fusco F, Pescatore A, Steffann J, Royer G, Bonnefont JP, Ursini MV, Eur J Hum Genet 2013 21 doi:10.1038/ejhg.2012.227
22. Incontinentia pigmenti diagnostic criteria update. Minić S, Trpinac D, Obradović M, Clin Genet 2014 85 536 542 10.1111/cge.12223 23802866
23. Two cases of misinterpretation of molecular results in incontinentia pigmenti, and a PCR-based method to discriminate NEMO/IKKγ gene deletion. Bardaro T, Falco G, Sparago A, Mercadante V, Gean Molins E, Tarantino E, Ursini MV, D'Urso M, Hum Mutat 2003 21 8 11 10.1002/humu.10150 12497627 (Pubitemid 36070452)
24. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. den Dunnen JT, Antonarakis SE, Hum Mutat 2000 15 7 15 Erratum in: Hum Mutat 2002, 20:403 10.1002/(SICI)1098-1004(200001)15:1<7:: AID-HUMU4>3.0.CO;2-N 10612815
25. Ursini MV, Conte MI, Pescatore A, Miano MG, Fusco F, Molecular Genetics of Incontinentia Pigmenti Chichester: eLS. John Wiley & Sons, Ltd 2012 doi:10.1002/9780470015902.a0024332